000 | 01353 a2200409 4500 | ||
---|---|---|---|
005 | 20250512023423.0 | ||
264 | 0 | _c19870410 | |
008 | 198704s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(87)90250-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVague, P | |
245 | 0 | 0 |
_aNicotinamide may extend remission phase in insulin-dependent diabetes. _h[electronic resource] |
260 |
_bLancet (London, England) _cMar 1987 |
||
300 |
_a619-20 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aVialettes, B | |
700 | 1 | _aLassmann-Vague, V | |
700 | 1 | _aVallo, J J | |
773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8533 _gp. 619-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(87)90250-9 _zAvailable from publisher's website |
999 |
_c2886992 _d2886992 |